Purinergic signaling during macrophage differentiation results in M2 alternative activated macrophages

被引:38
作者
Barbera-Cremades, Maria [1 ]
Baroja-Mazo, Alberto [1 ]
Pelegrin, Pablo [1 ]
机构
[1] Hosp Clin Univ Virgen de la Arrixaca IMIB Arrixac, Inst Murciano Invest Biosanitaria, Ctr Invest Biomed Red Area Temat Enfermedades Hep, Unidad Inflamac Mol & Cirugia Expt, Murcia, Spain
基金
欧洲研究理事会;
关键词
adenosine; Ym1; extracellular ATP; purinergic receptors; adenosine receptors; NUCLEOTIDE RECEPTORS; ADENOSINE; YM1; EXPRESSION; MONOCYTE; MURINE; POLARIZATION; RELEASE; PROTEIN; GAMMA;
D O I
10.1189/jlb.1A0514-267RR
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Macrophages represent a highly heterogenic cell population of the innate immune system, with important roles in the initiation and resolution of the inflammatory response. Purinergic signaling regulates both M1 and M2 macrophage function at different levels by controlling the secretion of cytokines, phagocytosis, and the production of reactive oxygen species. We found that extracellular nucleotides arrest macrophage differentiation from bone marrow precursors via adenosine and P2 receptors. This results in a mature macrophage with increased expression of M2, but not M1, genes. Similar to adenosine and ATP, macrophage growth arrested with LPS treatment resulted in an increase of the M2-related marker Ym1. Recombinant Ym1 was able to affect macrophage proliferation and could, potentially, be involved in the arrest of macrophage growth during hematopoiesis.
引用
收藏
页码:289 / 299
页数:11
相关论文
共 51 条
[1]   International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy [J].
Abbracchio, Maria P. ;
Burnstock, Geoffrey ;
Boeynaems, Jean-Marie ;
Barnard, Eric A. ;
Boyer, Jose L. ;
Kennedy, Charles ;
Knight, Gillian E. ;
Fumagalli, Marta ;
Gachet, Christian ;
Jacobson, Kenneth A. ;
Weisman, Gary A. .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :281-341
[2]  
Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101
[3]   Cutting edge:: Biasing immune responses by directing antigen to macrophage Fcγ receptors [J].
Anderson, CF ;
Mosser, DM .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3697-3701
[4]   Recent improvements in the development of A2B adenosine receptor agonists [J].
Baraldi, Pier Giovanni ;
Tabrizi, Mojgan Aghazadeh ;
Fruttarolo, Francesca ;
Romagnoli, Romeo ;
Preti, Delia .
PURINERGIC SIGNALLING, 2008, 4 (04) :287-303
[5]   Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3 [J].
Barczyk, Katarzyna ;
Ehrchen, Jan ;
Tenbrock, Klaus ;
Ahlmann, Martina ;
Kneidl, Jessica ;
Viemann, Dorothee ;
Roth, Johannes .
BLOOD, 2010, 116 (03) :446-455
[6]   A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin [J].
Chang, NCA ;
Hung, SI ;
Hwa, KY ;
Kato, I ;
Chen, JE ;
Liu, CH ;
Chang, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :17497-17506
[7]   Adenosine promotes alternative macrophage activation via A2A and A2B receptors [J].
Csoka, Balazs ;
Selmeczy, Zsolt ;
Koscso, Balazs ;
Nemeth, Zoltan H. ;
Pacher, Pal ;
Murray, Peter J. ;
Kepka-Lenhart, Diane ;
Morris, Sidney M., Jr. ;
Gause, William C. ;
Leibovich, S. Joseph ;
Hasko, Gyoergy .
FASEB JOURNAL, 2012, 26 (01) :376-386
[8]   Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase [J].
Defer, N ;
Best-Belpomme, M ;
Hanoune, J .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (03) :F400-F416
[9]   Nucleotide receptors: an emerging family of regulatory molecules in blood cells [J].
Di Virgilio, F ;
Chiozzi, P ;
Ferrari, D ;
Falzoni, S ;
Sanz, JM ;
Morelli, A ;
Torboli, M ;
Bolognesi, G ;
Baricordi, OR .
BLOOD, 2001, 97 (03) :587-600
[10]  
Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191